共 50 条
- [22] Real-World Comparison of First-Line Treatment Adherence Between Single-Agent Ibrutinib and Acalabrutinib in Patients with Chronic Lymphocytic Leukemia PATIENT PREFERENCE AND ADHERENCE, 2023, 17 : 2073 - 2084
- [24] Real-World Treatment Outcomes in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Who Were Treated With First-Line Single-Agent Ibrutinib vs Chemoimmunotherapy CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S330 - S330
- [27] Real-world treatment patterns in first line and relapsed Chronic Lymphocytic Leukemia (CLL) CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 : S204 - S205